Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00525109 · ClinicalTrials.gov registry record
Elevated Serum HDL in Four Generations of a Nashville Family
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 3
- Enrollment target
NCT00525109 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT00525109 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the genetic basis of one family's hereditary hyper-HDL-emia using multiple modalities such as linkage analysis and gene array.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00525109
The ClinicalTrials.gov registry entry for NCT00525109 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT00525109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00525109 about?
NCT00525109 is a clinical study titled "Elevated Serum HDL in Four Generations of a Nashville Family". The purpose of this study is to determine the genetic basis of one family's hereditary hyper-HDL-emia using multiple modalities such as linkage analysis and gene array.
What is the current status of trial NCT00525109?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2004-06. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00525109?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT00525109?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.